Berlin, Germany
Berlin, Germany

Time filter

Source Type

A method of depositing at least one substance on a target substrate (1) comprises the step of operating at least one droplet dispenser (21) such that droplets (2) including the at least one substance are deposited on the target substrate (1), wherein the target substrate (1) has a substrate surface including spatially delimited receptacle sections (3) being arranged for accommodating the droplets (2), and the at least one droplet dispenser (21) is controlled in dependency on the locations of the receptacle sections (3) such that the droplets (2) are directed onto the receptacle sections (3). Furthermore, a dispenser device (100) for depositing at least one substance on a target substrate (1) is described.


LFA (Lateral Flow Assay) market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.  The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. The Players mentioned in our report  GE healthcare  Merck Millipore  Sartorius  Pall  Kestrel Bio  Abingdon Health  BioDot, Inc  IMMY  Skannex  DCN  Qiagen  Senova  Scienion  ANP Technology, Inc  BBI Solutions  Cytodiagnostics Chapter 1 About the LFA (Lateral Flow Assay) Industry      1.1 Industry Definition        1.1.1 Types of LFA (Lateral Flow Assay) industry            1.1.1.1 Pregnancy            1.1.1.2 Drugs            1.1.1.3 Swine flue            1.1.1.4 HIV            1.1.1.5 Others      1.2 Main Market Activities      1.3 Similar Industries      1.4 Industry at a Glance Chapter 2 World Market Competition Landscape      2.1 LFA (Lateral Flow Assay) Markets by Regions        2.1.1 USA  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.2 Europe  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.3 China  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.4 India  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.5 Japan  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015        2.1.6 South East Asia  Market Revenue (M USD) by Types, Through 2021  Market Revenue (M USD) by Applications, Through 2021  Major Players Revenue (M USD) in 2015      2.2 World LFA (Lateral Flow Assay) Market by Types  Pregnancy  Drugs  Swine flue  HIV  Others      2.3 World LFA (Lateral Flow Assay) Market by Applications      2.4 World LFA (Lateral Flow Assay) Market Analysis        2.4.1 World LFA (Lateral Flow Assay) Market Revenue and Growth Rate 2011-2016        2.4.2 World LFA (Lateral Flow Assay) Market Consumption and Growth rate 2011-2016        2.4.3 World LFA (Lateral Flow Assay) Market Price Analysis 2011-2016 Chapter 3 World LFA (Lateral Flow Assay) Market share      3.1 Major Production Market share by Players      3.2 Major Revenue (M USD) Market share by Players      3.3 Major Production Market share by Regions in 2015, Through 2021      3.4 Major Revenue (M USD) Market share By Regions in 2015, Through 2021 For more information, please visit http://www.wiseguyreports.com


A method of electron microscopy imaging of samples, using an electron microscope (100) having a microscope column (10) and a transfer device (11) with a grid carriage (12), comprises the steps of preparing multiple samples (1) on a single electron microscopy grid (2), including dispensing the samples (1) with a dispenser device (30) on distinct positions on the grid (2), introducing the grid (1) with the transfer device (11) into the microscope column (10), and electron microscopy imaging of the samples (1), wherein the preparing step includes holding the grid (2) on the grid carriage (12) of the transfer device (11) or on a grid holder device (20) provided at the electron microscope (100) and dispensing the samples (1) on the grid (2) while holding it on the grid carriage (12) or on the grid holder device (20). Furthermore, an electron microscope (100) for electron microscopy imaging of samples is described.


A method of depositing at least one substance on a target substrate (1) comprises the step of operating at least one droplet dispenser (21) such that droplets (2) including the at least one substance are deposited on the target substrate (1), wherein the target substrate (1) has a substrate surface including spatially delimited receptacle sections (3) being arranged for accommodating the droplets (2), and the at least one droplet dispenser (21) is controlled in dependency on the locations of the receptacle sections (3) such that the droplets (2) are directed onto the receptacle sections (3). Furthermore, a dispenser device (100) for depositing at least one substance on a target substrate (1) is described.


Grant
Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: KBBE.2010.3.2-04 | Award Amount: 3.89M | Year: 2011

Monitoring the quality of drinking water is of paramount importance for public health. Water is not a commercial product but a heritage that must be protected, defended and treated as such (Water Framework Directive 2000/60/EC). The threat of waterborne diseases in Europe will predictably increase in the future as the human population increases and as a result of globalization and migration from non-EU countries and of climate change. Development of efficient, sensitive, robust, rapid and inexpensive tests to monitor various aspects of water quality represents an essential milestone within the strategy for control and prevention of diseases caused by waterborne pathogens and by algal toxins. Traditional methods for the detection of waterborne pathogens, based on cultivation, biochemical characterisation and microscopic detection are laborious and time-consuming; molecular biological tools have now greatly enhanced our ability to investigate biodiversity by identifying species and to estimate gene flow and distribution of species in time and space. AQUA aims to design and develop a universal microarray chip for the high-throughput detection in water of known and emerging pathogens (bacteria, viruses, protozoa and cyanobacteria) and to assess the water quality monitoring the presence of select bioindicators (i.e. diatoms). A chip able to detect cyanobacterial toxins will also be developed. These innovative molecular tools should be amenable to automation so that they could be deployed on moorings for routine semi-continuous monitoring of water quality. AQUA also aims to identify cyanophages potentially capable of controlling and mitigating the periodical blooming of toxic cyanobacteria in drinking water reservoirs. Overall, these innovative and cost efficient technologies will reduce energy requirements and improve performance of water treatment, and allow rapid management response to new situations brought about by environmental (including climatic) changes.


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate (10) and bottomless reaction chambers (20) are provided, the substrate (10) is first loaded with a biological agent and then the bottomless reaction chambers (20) are bonded glue-free to the substrate (10), in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate (10) suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber (20), wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber (20) to the substrate (10).


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


Patent
Scienion and Greiner Bio One Gmbh | Date: 2013-03-06

A process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


News Article | February 17, 2017
Site: www.prnewswire.co.uk

Research and Markets has announced the addition of the "Cell Analysis Global Market - Forecast to 2023" report to their offering. The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and a shortage of skilled labor for the high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment. The cell analysis global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions. - 4titude (U.K.) - AB Sciex (U.S.) - Abbott Laboratories, Inc. (U.S.) - Abcam PLC (U.S.) - Abdos (India) - Abnova Corporation (Taiwan) - ACEA Bioscience, Inc (U.S.) - Active Motif (U.S.) - Adnagen (U.S.) - Advanced Cell Diagnostics (U.S.) - Agilent Technologies, Inc. (U.S.) - Alere (U.S.) - Analytik Jena AG (Germany) - Apocell (U.S.) - Applied Microarrays (U.S.) - Ausragen (U.S.) - Auxilab S.L (Spain) - Avantes BV (Netherlands) - Aven Inc (U.S.) - Aviva Bioscience (U.S.) - Becton Dickinson and Company (U.S.) - BGI (China) - Bibby Scientific Limited (U.K.) - Bio Care Medical LLC (U.S.) - BioDot Inc. (U.S.) - Biofluidica (U.S.) - Biologics (China) - BioMerieux SA (Germany) - Bio-Rad Laboratories (U.S.) - Bioron (France) - Biosearch Technologies (U.S.) - BioView (Israel) - BMS microscopes (Netherlands) - Bruker (U.S.) - Canopus Bioscience (U.S.) - Capp ApS (Denmark) - Carl Zeiss AG (Germany) - Cell Signaling Technology, Inc. (U.S.) - Cell-Vu (U.S.) - Cherry Biotech (France) - Cisbio Bioassays (France) - Clearbridge BioMedics (Singapore) - Corning Inc (U.S.) - Creatv Microtech inc (U.S.) - Cyflogic (Finland) - Cynvenio Biosystems (U.S.) - Cytognos S.L. (Spain) - DaAn Gene (China) - Danaher Corporation (U.S.) - Danish Micro Engineering (Denmark) - Diagenode (Netherlands) - DiscoveRx (U.S.) - Domel (Slovenia) - Dragon Laboratory Instruments Ltd (China) - eBioscience, Inc., (U.S.) - Eppendorf (Germany) - Etaluma, Inc (U.S.) - Eurofins Scientific (Luxembourg) - EXIQON (Denmark) - FEI Company (U.S.) - Fluidgm Corporation (U.S.) - Fluxion Biosciences (U.S.) - GE Healthcare (U.K.) - Genedata AG (Switzerland) - Genemed Biotechnologies Inc (U.S.) - General Biologicals (Taiwan) - Gyros AB (Sweden) - Handyem (Canada) - Hausser Scientific (U.S.) - Herolab GmbH (Germany) - Hettich lab technology (Germany) - Hoffmann-La Roche (Switzerland) - HORIBA, Ltd. (Japan) - Illumina (U.S.) - Immunodiagnostics systems (France) - Jasco (U.S.) - Jena Biosciences (Germany) - JEOL, Ltd. (Japan) - Jasco Analytical Instruments (U.S.) - Kapa Biosystems (U.S.) - Keyence Corporation (U.S.) - Kyratec (Australia) - Labcon (U.S.) - Labnet International, Inc (U.S.) - Lubio Science (Switzerland) - Luminex Corporation (U.S.) - LW Scientific (U.S.) - Macrogen Inc (South Korea) - Medical Econet (Austria) - Meijo techno (U.K.) - Merck KGaA (Germany) - Mettler-Toledo, Inc. (U.S.) - Micro-shot Technology Ltd (China) - Miltenyil Biotec (Germany) - Nanostring Technologies (U.S.) - New England Biolabs (U.S.) - Nikon Corporation (Japan) - Olympus Corporation (Japan) - Optika SRL., (Italy) - Ortho Clinical Diagnostics (U.S.) - Ortoalresa (Spain) - Oxford Nanopore Technologies, Ltd. (U.K.) - Pacific Biosciences (U.S.) - Panagene (South Korea) - Park Systems (Korea) - PerkinElmer Inc (U.S.) - Pheonix (U.S.) - PicoQuant GmbH (Germany) - Promega Corporation (U.S.) - Qiagen N.V. (Netherlands) - Quest Diagnostics (U.S.) - R&D Systems (U.S.) - Rain Dance Technologies (U.S.) - Rheonix (U.S.) - Rigaku Corporation (Japan) - RR Mechatronics (Netherlands) - Sacace Biotechnologies (Italy) - Sanyo (Japan) - Scienion (Germany) - Scientific Specialities Inc (U.S.) - Seegene (South Korea) - Seimens Healthcare (Germany) - Separation Technology, Inc (U.S.) - Shimadzu Scientific Instruments (Japan) - Sigma Laborzentrifugen GmbH (Germany) - Sohn GmbH (Germany) - Sony Biotechnology (U.S.) - Sprenson Bioscience (U.S.) - Stemcell Technologies (Canada) - Sysmex (Japan) - Tecan (Switzerland) - The Western Electric & Scientific Works (India) - ThermoFisher Scientific Inc (U.S.) - Thorlabs (U.S.) - Toyo Gosei Co., Ltd (Japan) - TrimGen Genetic Diagnostics (U.S.) - Vision Scientific Co Ltd (Korea) - Visitron Systems Gmbh (Germany) - Waters Corporation (U.S.) - Yokogawa Electric Corporation (Japan) - Zymo Research (U.S.) For more information about this report visit http://www.researchandmarkets.com/research/ngm5k6/cell_analysis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Patent
Scienion | Date: 2012-08-22

The invention relates to a microdispenser (1) for dispensing a liquid sample in a dispensing device, with a sample container (2) for receiving the liquid sample, and with a nozzle (7) for dispensing the sample located in the sample container (2). The microdispenser (1) with the filled sample container (2) can in this case be stored independently of and fluidically separately from the dispensing device, without the sample escaping from the sample container (2) during storage.

Loading Scienion collaborators
Loading Scienion collaborators